Analytical Data
-
基因名
HADHSC
- Application
-
别名
3 hydroxyacyl Coenzyme A dehydrogenase; HAD; HADH; HADH1; HADHSC; HADHSC. formerly; HADSC. formerly; HCDH; HCDH_HUMAN; HHF4; Hydroxyacyl CoA dehydrogenase; Hydroxyacyl-coenzyme A dehydrogenase; hydroxyacyl-coenzyme A dehydrogenase. mitochondrial; L 3 hydroxyacyl Coenzyme A dehydrogenase short chain; M SCHAD; Medium and short chain L 3 hydroxyacyl coenzyme A dehydrogenase
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q16836
-
表达区间
1-314aa
-
氨基酸序列
MAFVTRQFMRSVSSSSTASASAKKIIVKHVTVIGGGLMGAGIAQVAAATGHTVVLVDQTEDILAKSKKGIEESLRKVAKKKFAENPKAGDEFVEKTLSTIATSTDAASVVHSTDLVVEAIVENLKVKNELFKRLDKFAAEHTIFASNTSSLQITSIANATTRQDRFAGLHFFNPVPVMKLVEVIKTPMTSQKTFESLVDFSKALGKHPVSCKDTPGFIVNRLLVPYLMEAIRLYERGDASKEDIDTAMKLGAGYPMGPFELLDYVGLDTTKFIVDGWHEMDAENPLHQPSPSLNKLVAENKFGKKTGEGFYKYK
-
分子量
60.28 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The HADHSC (Hydroxyacyl-CoA Dehydrogenase Short-Chain) is an enzyme that plays a critical role in the fatty acid oxidation pathway, influencing lipid metabolism and energy production. Research on HADHSC is driven by its significance in metabolic disorders, including obesity, diabetes, and cardiovascular diseases. Understanding the structure-function relationship of HADHSC can provide insights into its catalytic mechanisms and potential regulatory pathways. Recent studies have highlighted the importance of HADHSC in maintaining cellular energy homeostasis and its involvement in various physiological and pathological processes. The recombinant production of HADHSC allows for detailed characterization and examination of its enzymatic properties, paving the way for potential therapeutic applications. Investigating this enzyme can also lead to advancements in metabolic engineering and synthetic biology, whereby insights gained may facilitate the development of novel strategies for disease intervention and management. Overall, research on HADHSC not only enhances our understanding of lipid metabolism but also contributes to the identification of new targets for pharmacological intervention in metabolic diseases.
